Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.63 |
| ▸ | RAB9A | P51151 | 7/20 | 0.63 |
| ▸ | PPARG | P37231 | 1/20 | 0.63 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.63 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.63 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.63 |
| ▸ | ESRRG | P62508 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 5/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 5/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.56 |
| ▸ | RELA | Q04206 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18573537 | 0.93 | NPC1 (0.63) | NPC1RAB9APPARGNCOA2NCOA1 | |
| SCHEMBL12900103 | 0.85 | FABP3 (0.53) | NPC1RAB9AESRRGSMN1; SMN2MAPT | |
| SCHEMBL18573586 | 0.83 | NPC1 (0.63) | NPC1RAB9APPARGSMN1; SMN2MAPT | |
| SCHEMBL3748204 | 0.82 | HDAC6 (0.60) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL18573582 | 0.80 | PTPN1 (0.63) | NPC1RAB9APTPN1PTPN11SMN1; SMN2 | |
| SCHEMBL18573453 | 0.79 | RAB9A (0.60) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL14849810 | 0.78 | NPC1 (1.00) | NPC1RAB9APPARGNCOA2NCOA1 | |
| SCHEMBL12900100 | 0.78 | HDAC6 (0.55) | NPC1RAB9AESRRGSMN1; SMN2MAPT | |
| SCHEMBL18573454 | 0.77 | HDAC6 (0.55) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL18573581 | 0.77 | HPGD (0.54) | NPC1RAB9AESRRGSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3339299-B1 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2021-03-03 | — | — | EP | claimed |
| US-20200255397-A1 | METHOD FOR TREATING LIVER DISEASE BY ADMINISTERING PHARMACEUTICAL COMPOSITION COMPRISING CATECHOL DERIVATIVE | Autophagysciences Inc. (KR) | 2020-08-13 | — | — | US | claimed |
| US-20180244644-A1 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Autophagysciences Inc. (KR) | 2018-08-30 | — | — | US | claimed |
| EP-3339299-A2 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences, Inc (KR) | 2018-06-27 | — | — | EP | claimed |
| EP-3339299-B1 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2021-03-03 | — | — | EP | disclosed |
| US-20200255397-A1 | METHOD FOR TREATING LIVER DISEASE BY ADMINISTERING PHARMACEUTICAL COMPOSITION COMPRISING CATECHOL DERIVATIVE | Autophagysciences Inc. (KR) | 2020-08-13 | — | — | US | disclosed |
| US-20200255397-A1 | METHOD FOR TREATING LIVER DISEASE BY ADMINISTERING PHARMACEUTICAL COMPOSITION COMPRISING CATECHOL DERIVATIVE | Autophagysciences Inc. (KR) | 2020-08-13 | — | — | US | disclosed |
| US-10662169-B2 | Catechol derivative and pharmaceutical composition comprising the same | Autophagysciences Inc. (KR) | 2020-05-26 | — | — | US | disclosed |
| US-10662169-B2 | Catechol derivative and pharmaceutical composition comprising the same | Autophagysciences Inc. (KR) | 2020-05-26 | — | — | US | disclosed |
| US-20180244644-A1 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Autophagysciences Inc. (KR) | 2018-08-30 | — | — | US | disclosed |
| EP-3339299-A2 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences, Inc (KR) | 2018-06-27 | — | — | EP | disclosed |
| WO-2017034242-A2 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 유영제약 | 2017-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255397-A1 | METHOD FOR TREATING LIVER DISEASE BY ADMINISTERING PHARMACEUTICAL COMPOSITION COMPRISING CATECHOL DERIVATIVE | ATG7, BECN1, SLC10A1 | NPC1 27/4885RAB9A 167/4885PPARG 1167/4885 |
| US-10662169-B2 | Catechol derivative and pharmaceutical composition comprising the same | BECN1, ATG7, SQSTM1 | NPC1 45/4885RAB9A 197/4885PPARG 1056/4885 |
| US-20180244644-A1 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | BECN1, ATG7, TFEB | NPC1 40/4885RAB9A 122/4885PPARG 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.